Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes
Tobacco smoking continues to be a leading cause of preventable death. Recent research has underscored the important role of specific cholinergic nicotinic receptor subunit (CHRN) genes in risk for nicotine dependence and smoking. To detect and characterize the influence of genetic variation on vulne...
Saved in:
Published in: | American journal of medical genetics. Part B, Neuropsychiatric genetics Vol. 150B; no. 4; pp. 453 - 466 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
05-06-2009
Wiley-Liss |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Tobacco smoking continues to be a leading cause of preventable death. Recent research has underscored the important role of specific cholinergic nicotinic receptor subunit (CHRN) genes in risk for nicotine dependence and smoking. To detect and characterize the influence of genetic variation on vulnerability to nicotine dependence, we analyzed 226 SNPs covering the complete family of 16 CHRN genes, which encode the nicotinic acetylcholine receptor (nAChR) subunits, in a sample of 1,050 nicotine‐dependent cases and 879 non‐dependent controls of European descent. This expanded SNP coverage has extended and refined the findings of our previous large‐scale genome‐wide association and candidate gene study. After correcting for the multiple tests across this gene family, we found significant association for two distinct loci in the CHRNA5–CHRNA3–CHRNB4 gene cluster, one locus in the CHRNB3–CHRNA6 gene cluster, and a fourth, novel locus in the CHRND–CHRNG gene cluster. The two distinct loci in CHRNA5–CHRNA3–CHRNB4 are represented by the non‐synonymous SNP rs16969968 in CHRNA5 and by rs578776 in CHRNA3, respectively, and joint analyses show that the associations at these two SNPs are statistically independent. Nominally significant single‐SNP association was detected in CHRNA4 and CHRNB1. In summary, this is the most comprehensive study of the CHRN genes for involvement with nicotine dependence to date. Our analysis reveals significant evidence for at least four distinct loci in the nicotinic receptor subunit genes that each influence the transition from smoking to nicotine dependence and may inform the development of improved smoking cessation treatments and prevention initiatives. © 2009 Wiley‐Liss, Inc. |
---|---|
Bibliography: | National Cancer Institute - No. P01 CA89392 National Institute on Alcohol Abuse and Alcoholism - No. K01 AA015572 ark:/67375/WNG-QFZN7GBX-L ArticleID:AJMG30828 National Institute on Drug Abuse - No. R01 DA012854; No. R01 DA014369; No. K08 DA019951; No. K01 DA015129 Conflicts of Interest: Drs. S.F. Saccone, A.L. Hinrichs, J.C. Wang, A.M. Goate, J.P. Rice and L.J. Bierut are listed as inventors on a patent (US 20070258898) held by Perlegen Sciences, Inc., covering the use of certain SNPs in determining the diagnosis, prognosis, and treatment of addiction. Dr. N.L. Saccone is the spouse of S.F. Saccone, who is listed on the above-named patent. Dr. Bierut has acted as a consultant for Pfizer, Inc. in 2008. American Cancer Society - No. IRG-58-010-50 istex:BBF18F591D11FDA8C1CAA193EC5479FF82121A95 How to Cite this Article: Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, Pergadia ML, Agrawal A, Breslau N, Grucza RA, Hatsukami D, Johnson EO, Madden PAF, Swan GE, Wang JC, Goate AM, Rice JP, Bierut LJ. 2009. Multiple Distinct Risk Loci for Nicotine Dependence Identified by Dense Coverage of the Complete Family of Nicotinic Receptor Subunit (CHRN) Genes. Am J Med Genet Part B 150B:453-466. Conflicts of Interest: Drs. S.F. Saccone, A.L. Hinrichs, J.C. Wang, A.M. Goate, J.P. Rice and L.J. Bierut are listed as inventors on a patent (US 20070258898) held by Perlegen Sciences, Inc., covering the use of certain SNPs in determining the diagnosis, prognosis, and treatment of addiction. Dr. N.L. Saccone is the spouse of S.F. Saccone, who is listed on the above‐named patent. Dr. Bierut has acted as a consultant for Pfizer, Inc. in 2008. CHRN Genes. Am J Med Genet Part B 150B:453–466. How to Cite this Article: Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, Pergadia ML, Agrawal A, Breslau N, Grucza RA, Hatsukami D, Johnson EO, Madden PAF, Swan GE, Wang JC, Goate AM, Rice JP, Bierut LJ. 2009. Multiple Distinct Risk Loci for Nicotine Dependence Identified by Dense Coverage of the Complete Family of Nicotinic Receptor Subunit ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 1552-4841 1552-485X 1552-485X |
DOI: | 10.1002/ajmg.b.30828 |